Doxorubicin hydrochloride

Lieferant: MP Biomedicals

Synonyme: Doxorubicin HCl, Hydroxydaunorubicin Hydrochloride, (8S,10S)-10-(((2R,4S,5S,6S)-4-Amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione hydrochloride

0215910110
ICNA0215910110EA 261 EUR
ICNA0215910110
Doxorubicin hydrochloride
Doxorubicin hydrochloride

Doxorubicin Hydrochloride is a chemotherapeutic, antitumour, immunosuppressive, and antibiotic agent.


Doxorubicin hydrochloride blocks RNA polymerase and reverse transcriptase. It also inhibits nucleic acid synthesis and induces apoptosis. Naturally fluorescent anthracycline antibiotic, anticancer drug. Doxorubicin is a substrate of MRP1 which was first cloned from a DOX-resistant lung cancer cell line. The fluorescent property has been exploited for the measurement of drug efflux pump activities as well as resolving the important question of intracellular localisation of various multidrug resistance proteins and the role of subcellular organelles (Golgi and lysosome) in the sequestration of drugs and its implication in drug resistant phenotypes.


Fluorescence: Emmax: 585 nm (Exc.: 470 nm in ethanol) (Lit.).


Soluble in water (> 10 mg/ml), in isotonic sodium chloride, methanol, aqueous alcohols, DMSO (>10 mg/ml); practically insoluble in chloroform, ether, and other organic solvents.

Formel: C₂₇H₂₉NO₁₁·HCl
Molecular Weight: 579,98 g/mol
MDL: MFCD00077757
CAS-Nummer: 25316-40-9

Bestellen

Spezifikation Testergebnisse

Form Reddish Orange Powder
Storage Store at Room Temperature (15 - 30 °C)

Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Mehr About VWR